Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Inks Commercialization Deal for miRNA Tests with Genetic Technologies

Premium

Rosetta Genomics this week announced that it has signed an agreement making Australia's Genetic Technologies the exclusive distributor of its three miRview microRNA-based diagnostics in Australia, New Zealand, and Singapore.

Under the deal, Genetic Technologies will market Rosetta's miRview Meso, which differentiates lung cancer from mesothelioma; miRview Mets, which is designed to determine the source of cancers of unknown primary origin; and miRview Squamous, which is designed to differentiate squamous from non-squamous non-small cell lung cancer.

"This is an important first step in Genetic Technologies' move from predictive gene tests into advanced cancer management," Genetic Technologies CEO Paul MacLeman said in a statement.

Financial terms of the arrangement were not disclosed.

Rosetta's arrangement with Genetic Technologies comes a little more than a month after the miRNA shop licensed the Italian rights to the diagnostics to AXA Diagnostics (see RNAi News, 9/10/2009).

In August, Rosetta announced that it has licensed the rights to the diagnostics in India, Saudi Arabia, Qatar, and the United Arab Emirates to India’s Super Religare Laboratories (see RNAi News, 8/20/2009). That same month, Rosetta licensed the diagnostics’ Canadian market rights to Warnex Medical Laboratories (see RNAi News, 8/13/2009).

In April, Rosetta signed a deal giving Prometheus Laboratories the US rights to the three tests (see RNAi News, 4/16/2009). Prometheus has since launched the tests under its ProOnc line (see RNAi News, 10/15/2009).

In January, it licensed the Israeli and Turkish rights to Teva Pharmaceuticals (see RNAi News, 1/8/2009).

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.